NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2032220496

Registered date:08/12/2022

PASSAGE Clinical Trial

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedUnresectable malignant gastric outlet obstruction
Date of first enrollment23/12/2022
Target sample size51
Countries of recruitment
Study typeInterventional
Intervention(s)Investigational device (BSJ018A) will be implanted in the EUS-guided gastrojejunostomy

Outcome(s)

Primary OutcomeGOOSS 3 rate without MAE at 30 days post procedure
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteriaUnresectable malignant duodenal obstruction confirmed by biopsy Eligible for endoscopic intervention GOOSS score of 0 or 1 18 years of age or older Willing and able to comply with the study procedures or legally authorized representative (LAR) must provide written informed consent form (ICF) to participate in the study
Exclude criteriaExclusion Criteria at informed consent Prior metallic stent placement for GOO Contraindicated to surgery and general anesthesia Neoplasm invading the target site of puncture in gastric and/or jejunum Altered anatomy of the upper gastrointestinal tract due to surgery of esophagus, stomach and duodenum that might preclude endoscopic drainage Presence of ileus caused by peritoneal carcinomatosis, or expected to present within 30 days post procedure Intervening gastric varices or vessels at the target site of stent insertion Ascites that may interfere the safety of the index procedure Subject is currently participating, or plans to participate in, another investigational trial that may confound the results of this trial (unless written approval is received from the Boston Scientific study team) Vulnerable subject Exclusion Criteria at the index procedure Guidewire does not cross the area of GOO EP-DB does not advance to the target site in jejunum The distance between the gastric wall and jejunal wall when visualized on ultrasound after saline is introduced into the space between the two inflated balloons of EP-DB is deemed about 2 cm or more

Related Information

Contact

Public contact
Name Ryo Konishi
Address 4-10-2 Nakano, Nakano-ku, Tokyo Tokyo Japan 164-0001
Telephone +81-3-6853-7500
E-mail JapanClinicalTrials@bsci.com
Affiliation Boston Scientific Japan K.K.
Scientific contact
Name Kazuo Kawahara
Address 4-10-2 Nakano, Nakano-ku, Tokyo Tokyo Japan 164-0001
Telephone +81-3-6853-7500
E-mail JapanClinicalTrials@bsci.com
Affiliation Boston Scientific Japan K.K.